IL-17, IL-23 Therapies Lead Psoriasis Care

• by Andrea Surnit

• April 12, 2026

Modified Delphi Consensus Recommendations for the Management of Psoriasis in Asia–Pacific

• by Yoo Sang Baek, Siew Eng Choon, Peter Anthony Foley, Tsen Fang Tsai, Jianzhong Zhang, Yukie Yamaguchi

• July 1, 2026

FDA Approves Pediatric Risankizumab

Approval expands risankizumab use to pediatric plaque psoriasis and psoriatic arthritis and includes a new 55-mg prefilled syringe for weight-based dosing in patients weighing less than 40 kg.

• by Kathryn Wighton

• June 29, 2026

• 3 min

Mental Health May Impact Dermatologic Quality of Life

Poorer dermatology-related quality of life was associated with greater mental health issues, while habitual probiotic intake showed no measurable relationship with these outcomes.

• by Andrea Surnit

• July 9, 2026

• 3 min